| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 64.84B | 61.89B | 66.06B | 64.69B | 60.74B | 54.78B |
| Gross Profit | 14.51B | 14.59B | 14.47B | 13.99B | 11.09B | 10.48B |
| EBITDA | 7.27B | 6.82B | 7.41B | 7.00B | 4.81B | 4.68B |
| Net Income | 4.99B | 5.25B | 4.94B | 3.95B | 2.10B | 1.30B |
Balance Sheet | ||||||
| Total Assets | 83.79B | 85.38B | 85.24B | 87.46B | 82.03B | 79.79B |
| Cash, Cash Equivalents and Short-Term Investments | 16.29B | 15.82B | 16.23B | 15.89B | 10.87B | 8.95B |
| Total Debt | 4.10B | 2.85B | 3.53B | 3.98B | 7.38B | 8.85B |
| Total Liabilities | 21.53B | 18.35B | 21.13B | 27.89B | 29.82B | 30.06B |
| Stockholders Equity | 56.30B | 60.23B | 57.46B | 53.40B | 46.19B | 44.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.85B | 1.72B | 8.07B | 3.91B | 2.78B |
| Operating Cash Flow | 0.00 | 6.42B | 3.12B | 9.32B | 6.20B | 5.02B |
| Investing Cash Flow | 0.00 | -5.19B | -1.24B | 533.00M | -1.59B | -1.27B |
| Financing Cash Flow | 0.00 | -4.77B | -2.04B | -5.09B | -2.82B | -1.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥52.52B | 8.97 | ― | 5.04% | -6.31% | 6.66% | |
73 Outperform | ¥148.24B | 11.18 | 6.23% | 1.11% | 3.36% | 14.17% | |
69 Neutral | ¥2.40T | 11.00 | 11.64% | 1.52% | 11.97% | 45.59% | |
69 Neutral | ¥557.92B | 21.11 | ― | 3.26% | 15.83% | 124.18% | |
63 Neutral | ¥395.07B | 13.04 | 13.71% | 3.38% | 0.16% | -12.55% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
52 Neutral | ¥35.55B | 20.68 | ― | 3.70% | 29.30% | -82.16% |